Hong Kong stocks are moving uniquely | Amgen-B (09606.HK) opens over 4% higher and is included in the Hang Seng Composite Index constituent stocks Breast cancer new drug phase III clinical trials achieve main endpoints.

According to the "Securities Times" app, Ying En Biotech-B (09606.HK) opened over 4% higher, as of the time of publication, it increased by 4.63% to 380 Hong Kong dollars, with a turnover of 7.506 million Hong Kong dollars.